FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1516-1517 December 1, 1994 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

At the beginning of this century, while he was developing schedules for the treatment of syphilis with arsphenamine, Ehrlich discovered that inadequate therapy for early syphilis was followed within 6 to 12 months by the appearance of neurologic disease that he called neurorecurrence.¹ This early neurosyphilis was unlike typical tertiary neurosyphilis, which develops after a much longer period of latency, in that it involved mesodermal rather than ectodermal tissues and, consequently, was characterized by acute meningitis, cranial-nerve abnormalities, or stroke rather than by dementia, psychosis, or tabes dorsalis. In the 1930s Merritt and his coworkers¹ observed only 80 patients with . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.